Vacuna personalizada de ARNm reduce riesgo de melanoma
Vacuna personalizada de ARNm reduce riesgo de recurrencia de melanoma en un 42%, según ensayo clínico.
World Headlines Newsroom
44,488Artículos
Acerca de
World Headlines Newsroom reports on global events across 21 languages. Each article synthesizes firsthand reporting from verified sources — wire services, regional outlets, and specialist publications — into multi-perspective, context-rich journalism. Our editorial process applies source verification, fact-checking, and editorial review before publication. Founded to serve readers who want depth beyond headlines.
